Search results - 6 results
Clinical Evolution and Disease Burden in Belgian Cystic Fibrosis Patients: effect of Newborn Screening?
Belgian CF Registry report of 2016 including patients diagnosed between January 2006 and December 2016. Results: 306 CF patients were enrolled. Age at diagnosis was the lowest in MI patients (median 0.12 ...
Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe.
estimate incidence, describe clinical presentation and investigate factors associated with severe outcomes using multivariable analysis. RESULTS: Up to December 31, 2020, 26 countries reported information on ...
Annual Report Belgian Cystic Fibrosis Registry 2018
the patients up to 20 years, the proportion with BMI below the tenth percentile has also been declining over the years. The results above suggest better nutritional and global management in the ...
Risk factors and impact of allergic bronchopulmonary aspergillosis in Pseudomonas aeruginosa-negative CF patients.
mutation (homozygous or heterozygous), and Pa colonization. RESULTS: Median FEV at the year of diagnosis (index year) was significantly lower in patients with ABPA. The median of cumulative values of FEV and ...
The burden of cystic fibrosis in Belgium: a registry-based study
using a prevalence approach (hybrid model) in a multi-aspect disease model. Results: In 2014, patients with cystic fibrosis in Belgium are accountable for 484.8 YLL s and 437.6 YLD s, corresponding with ...
Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study.
regression was used to investigate factors associated with clinical progression to severe COVID-19, using the primary outcome of hospitalisation with supplemental oxygen. RESULTS: SARS-CoV-2 was reported in ...